INSITE VISION INCORPORATED has a total of 12 patent applications. Its first patent ever was published in 1991. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, medical technology and machines are DOLORGIET GMBH & CO KG, ARROWDEAN LTD and RTP PHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Machines | |
#4 | Computer technology | |
#5 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Unspecified technologies | |
#4 | Implantable devices | |
#5 | Electric digital data processing | |
#6 | Syringes | |
#7 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Bowman Lyle M | 10 |
#2 | Hosseini Kamran | 5 |
#3 | Nguyen Tang | 3 |
#4 | Hou Sui Yuen Eddie | 3 |
#5 | Chandrasekaran Santosh Kumar | 3 |
#6 | Bowman Lyle | 2 |
#7 | Peyman Gholam | 2 |
#8 | Si Erwin C | 2 |
#9 | Babcock John C | 2 |
#10 | Tsao Sheng-Wang | 1 |
Publication | Filing date | Title |
---|---|---|
WO2017007609A1 | Ocular treatment with reduced intraocular pressure | |
US2017065552A1 | Ophthalmic formulations of mycophenolic acid | |
EP2968383A1 | Concentrated aqueous azalide formulations | |
CA2753947A1 | Non-steroidal anti-inflammatory ophthalmic compositions |